Companies in the neuroscience sector developing innovative solutions and technologies.
Explore 340 recently funded neuroscience companies with verified founder contact information and fundraising data.
MaxWell Biosystems provides solutions to advance basic neuroscience research and accelerate preclinical drug discovery.
nQ Medical is a neurotechnology company allowing Data Defined Disease Management via digital biomarkers using AI.
Neuro-ID provides behavioral analytics identity solutions for banks, fintech, and insurance industries.
Braingrade developing a new solution for patients with Alzheimer’s Disease.
Cortical.io offers AI-based solutions for intelligent document processing leveraging a proprietary technology inspired by neuroscience.
NeuroNation is a digital health research and development company on a mission to help 25M+ users to maintain and regain a strong brain.
Mindspeller develops a human-centric AI to uncover the intuitive mind and drives consumer behavior.
IDUN Technologies is developing the Internet of Humans, a world where devices and apps react to your emotional needs.
NeuroVision Imaging is a developer of digital imaging and diagnostic solutions for Alzheimer's disease.
Cerecor discovers, develops and commercializes neuroscience drugs.
Constant Therapy Health is a digital therapeutics company and maker of the award-winning app, Constant Therapy.
BrainPatch is a Neurotechnology startup disrupting the industry of non-invasive brain stimulation.
Imagine a society in which every human could pursue whatever goal they want. Say hey to your new life. Say heyvie.
AgenT develops the first blood diagnosis to detect Alzheimer's disease from the asymptomatic stage.
The neuroscience sector is an active area of startup innovation and venture capital investment. Companies in this space are developing new technologies, platforms, and services that address evolving market needs and create new business opportunities.
Neuroscience companies raise capital across various funding stages, from early seed rounds to late-stage growth financing. Investor interest in this sector is driven by the size of the addressable market, the pace of technology adoption, and the potential for scalable business models.
The neuroscience sector is expected to continue evolving as technology advances, market dynamics shift, and new opportunities emerge. Companies that demonstrate strong product-market fit, efficient growth, and clear competitive advantages are well-positioned to attract continued investment.
Here is how funding is distributed among the 340 neuroscience companies tracked in the VCBacked database.
Companies in the neuroscience sector often overlap with or complement businesses in adjacent industries. Exploring related verticals can help you discover additional companies, identify partnership opportunities, and understand the broader competitive landscape.
Perfect for: B2B sales teams targeting neuroscience companies, investors exploring sector opportunities, and service providers looking for funded companies ready to scale.
Get Started - Access Contact InformationJoin thousands of sales teams, investors, and service providers using VCBacked